The estimated Net Worth of William G Dempsey is at least $52.4 Milion dollars as of 7 August 2007. Mr. Dempsey owns over 124,436 units of Hill-Rom Inc stock worth over $50,093,728 and over the last 21 years he sold HRC stock worth over $1,878,105. In addition, he makes $382,148 as Non-Executive Independent Chairman of the Board at Hill-Rom Inc.
William has made over 15 trades of the Hill-Rom Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently he exercised 124,436 units of HRC stock worth $5,262,398 on 7 August 2007.
The largest trade he's ever made was exercising 124,436 units of Hill-Rom Inc stock on 7 August 2007 worth over $5,262,398. On average, William trades about 10,569 units every 29 days since 2003. As of 7 August 2007 he still owns at least 321,196 units of Hill-Rom Inc stock.
You can see the complete history of Mr. Dempsey stock trades at the bottom of the page.
William G. Dempsey serves as Non-Executive Independent Chairman of the Board of the Company. Mr. Dempsey previously held various executive positions with Abbott Laboratories from 1982 until 2007, including Executive Vice President of Global Pharmaceuticals from 2006, Senior Vice President of Pharmaceutical Operations from 2003 and Senior Vice President of International Operations from 1999. He currently serves as a director of Ashland, Inc. (where he serves on the audit, and governance and nominating committees), and was previously on the boards of Nordion, Inc. through 2014, Hospira, Inc., through 2015 and Landauer Inc., through 2017. He has previously served as a member of the Salvation Army Advisory Board in Chicago, as Chairman of the International Section of the Pharmaceutical Research and Manufacturers of America (PhRMA) and as Chairman of the Accelerating Access Initiative (a cooperative public-private partnership of UNAIDS, the World Bank, and six research-based pharmaceutical companies). He is a member of the Board of Trustees for the Guadalupe Center in Immokalee, Florida.
As the Non-Executive Independent Chairman of the Board of Hill-Rom Inc, the total compensation of William Dempsey at Hill-Rom Inc is $382,148. There are 9 executives at Hill-Rom Inc getting paid more, with John Groetelaars having the highest compensation of $7,326,160.
William Dempsey is 68, he's been the Non-Executive Independent Chairman of the Board of Hill-Rom Inc since 2018. There are 1 older and 25 younger executives at Hill-Rom Inc. The oldest executive at Hill-Rom Holdings Inc is William Kucheman, 70, who is the Independent Director.
William's mailing address filed with the SEC is 8145 BLAZER DRIVE, , WILMINGTON, DE, 19808.
Over the last 17 years, insiders at Hill-Rom Inc have traded over $30,589,508 worth of Hill-Rom Inc stock and bought 112,784 units worth $2,597,878 . The most active insiders traders include John J Greisch, W August Hillenbrand a James R Giertz. On average, Hill-Rom Inc executives and independent directors trade stock every 20 days with the average trade being worth of $1,650,525. The most recent stock trade was executed by Andreas G Frank on 6 December 2021, trading 361 units of HRC stock currently worth $56,302.
Hillrom Holdings Inc. is a global medical technology leader whose 10,000 employees have a single purpose: enhancing outcomes for patients and their caregivers by Advancing Connected Care™. Around the world, its innovations touch over 7 million patients each day. They help enable earlier diagnosis and treatment, optimize surgical efficiency and accelerate patient recovery while simplifying clinical communication and shifting care closer to home. The company makes these outcomes possible through connected smart beds, patient lifts, patient assessment and monitoring technologies, caregiver collaboration tools, respiratory health devices, advanced operating room equipment and more, delivering actionable, real-time insights at the point of care.
Hill-Rom Inc executives and other stock owners filed with the SEC include: